Distinct requirements for PI3K isoforms p110α and p110δ for PIP3 synthesis in mouse oocytes and early embryos
Development · 2025
DOI: 10.1242/dev.204398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Development, 2025. Verfasst von Anne Bourdais und 8 weiteren Autor:innen. Beteiligte Einrichtung: Université de Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, F-35000 Rennes, France. Hauptthemen laut MEDLINE: Oocytes, Phosphatidylinositol Phosphates, Class I Phosphatidylinositol 3-Kinases, Embryo, Mammalian. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 138 Literaturangaben. Gefördert von: Agence de la Biomedecine, Region Bretagne, Association pour la Recherche sur le Cancer.
Abstract (Originalsprache)
The phosphoinositide 3-kinase (PI3K)/Akt pathway is thought to regulate key steps of mammalian oogenesis, such as dormant oocyte awakening during follicular activation, meiotic resumption and oocyte maturation. Supporting evidence is, however, indirect, as oocyte PI3K activation has never been formally demonstrated, and the PI3K isoforms involved have not been revealed. Here, we employed fluorescent PIP3 biosensors to characterize PI3K dynamics in mouse oocytes and we investigated the contribution of the PI3K isoform p110α by conditional genetic ablation. Prophase oocytes showed baseline PI3K/Akt activation that could be further stimulated by adding Kit ligand. Contrary to previous reports, maternal PI3K proved dispensable for oocyte maturation in vitro, yet it was required for PIP3 synthesis in early embryos. We further show that oocyte p110α is not essential for oogenesis and female fertility. Accordingly, our data suggest that Kit ligand activates isoform p110δ for PIP3 synthesis in oocytes. In contrast, constitutive PIP3 synthesis in early embryos is achieved by maternal p110α acting redundantly with p110δ. This study highlights the relevance of PIP3 biosensors in establishing the dynamics, mechanisms and roles of maternal PI3K signaling during mammalian oogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université de Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, F-35000 Rennes, France.
- Department of Chemical Biology, ZMB, Faculty of Biology, University of Duisburg-Essen, Universitätsstrasse 2, 45117 Essen, Germany.
- CRCT, Université de Toulouse, INSERM, CNRS, Université Toulouse III-Paul Sabatier, Centres de Recherches en Cancérologie de Toulouse, Toulouse, France.
- Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia.
ORCID-Profile: Anne Bourdais, Nicole Therville, Julie Guillermet-Guibert, John Carroll, Guillaume Halet
Förderung
- Agence de la Biomedecine
- Region Bretagne
- Association pour la Recherche sur le Cancer
- Institut des sciences biologiques
- Centre National de la Recherche Scientifique
- Agence de la Biomédecine
- Région Bretagne
- Medical Research Council
Zitieren
APA
Bourdais, A., Viard, P., Bormann, J., Sesboüé, C., Guerrier, D., Therville, N., Guillermet-Guibert, J., Carroll, J., & Halet, G. (2025). Distinct requirements for PI3K isoforms p110α and p110δ for PIP3 synthesis in mouse oocytes and early embryos. Development. https://doi.org/10.1242/dev.204398
Vancouver
Bourdais A, Viard P, Bormann J, Sesboüé C, Guerrier D, Therville N, et al. Distinct requirements for PI3K isoforms p110α and p110δ for PIP3 synthesis in mouse oocytes and early embryos. Development. 2025. doi:10.1242/dev.204398
BibTeX
@article{Bourdais2025,
author = {Bourdais, Anne and Viard, Patricia and Bormann, Jenny and Sesboüé, Côme and Guerrier, Daniel and Therville, Nicole and Guillermet-Guibert, Julie and Carroll, John and Halet, Guillaume},
title = {Distinct requirements for PI3K isoforms p110α and p110δ for PIP3 synthesis in mouse oocytes and early embryos},
journal = {Development},
year = {2025},
doi = {10.1242/dev.204398}
}
EUVIMED